These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8199607)

  • 41. Attitudes of morbidly obese patients to weight loss and body image following bariatric surgery and body contouring.
    Pecori L; Serra Cervetti GG; Marinari GM; Migliori F; Adami GF
    Obes Surg; 2007 Jan; 17(1):68-73. PubMed ID: 17355771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 2 diabetes and weight loss following biliopancreatic diversion for obesity.
    Marinari GM; Papadia FS; Briatore L; Adami G; Scopinaro N
    Obes Surg; 2006 Nov; 16(11):1440-4. PubMed ID: 17132408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between weight-preoccupied women and anorexia nervosa.
    Garner DM; Olmsted MP; Polivy J; Garfinkel PE
    Psychosom Med; 1984; 46(3):255-66. PubMed ID: 6739685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Survey of disordered eating and behaviour in children and adolescents].
    Thiels C; Pätel J
    Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):265-74. PubMed ID: 18654958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity.
    Alexandrides TK; Skroubis G; Kalfarentzos F
    Obes Surg; 2007 Feb; 17(2):176-84. PubMed ID: 17476868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is laparoscopic single-stage biliopancreatic diversion with duodenal switch safe in super morbidly obese patients?
    Rezvani M; Sucandy I; Klar A; Bonanni F; Antanavicius G
    Surg Obes Relat Dis; 2014; 10(3):427-30. PubMed ID: 24439116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-term changes in serum leptin concentration following biliopancreatic diversion.
    Marinari GM; Camerini G; Cella F; Scopinaro N; Adami GF
    Obes Surg; 2000 Oct; 10(5):442-4. PubMed ID: 11054249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity.
    Adami GF; Campostano A; Gandolfo P; Marinari G; Bessarione D; Scopinaro N
    Eur Surg Res; 1996; 28(4):295-8. PubMed ID: 8813654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic biliopancreatic diversion with duodenal switch.
    Feng JJ; Gagner M
    Semin Laparosc Surg; 2002 Jun; 9(2):125-9. PubMed ID: 12152155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laparoscopic biliopancreatic diversion for the treatment of morbid obesity: initial experience.
    Paiva D; Bernardes L; Suretti L
    Obes Surg; 2001 Oct; 11(5):619-22. PubMed ID: 11594106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biliopancreatic diversion (doudenal switch procedure).
    Marceau P; Hould FS; Potvin M; Lebel S; Biron S
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):99-103. PubMed ID: 10102218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients.
    Topart P; Becouarn G; Ritz P
    Surg Obes Relat Dis; 2013; 9(4):526-30. PubMed ID: 22498360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laparoscopic biliopancreatic diversion: technique and initial results.
    Paiva D; Bernardes L; Suretti L
    Obes Surg; 2002 Jun; 12(3):358-61. PubMed ID: 12082887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biliopancreatic Diversion for Severe Obesity: Long-Term Effectiveness and Nutritional Complications.
    Ballesteros-Pomar MD; González de Francisco T; Urioste-Fondo A; González-Herraez L; Calleja-Fernández A; Vidal-Casariego A; Simó-Fernández V; Cano-Rodríguez I
    Obes Surg; 2016 Jan; 26(1):38-44. PubMed ID: 25982805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body weight and satiation after duodenal switch: 2 years later.
    Paradis S; Cabanac M; Marceau P; Frankham P
    Obes Surg; 2007 May; 17(5):631-6. PubMed ID: 17658022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up.
    de Luis DA; Pacheco D; Izaola O; Terroba MC; Cuellar L; Martin T
    Ann Nutr Metab; 2008; 53(3-4):234-9. PubMed ID: 19088468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Venous thromboembolism after laparoscopic biliopancreatic diversion with duodenal switch: analysis of 362 patients.
    Rezvani M; Sucandy I; Das R; Naglak MC; Bonanni FB; Antanavicius G
    Surg Obes Relat Dis; 2014; 10(3):469-73. PubMed ID: 24342034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prader-Willi syndrome-associated obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review.
    Papavramidis ST; Kotidis EV; Gamvros O
    J Pediatr Surg; 2006 Jun; 41(6):1153-8. PubMed ID: 16769352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of biliopancreatic diversion in the patients with bulimia nervosa.
    Yashkov YI; Bekuzarov DK
    Obes Surg; 2006 Nov; 16(11):1433-9. PubMed ID: 17132407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.